FIG FRUIT EXTRACT – ABAlife®

ABAlife® is a patented fig fruit extract (Ficus carica L.) standardized to abscisic acid (ABA).

An acute clinical trial showed its potential in managing blood sugar levels by controlling glycemic and insulinemic indices. In a type 2 diabetes animal model study, oral administration of Abalife® improved glucose tolerance, insulin sensitivity, and fasting blood glucose. It also enhanced metabolic flexibility, facilitating better energy utilization in the body

Study on Glycemic Management

Study on Insulin Sensitivity

Our figs are sustainably grown in Spain and processed at our Euromed facilities in Murcia, Spain, using the innovative Pure-Hydro Process® to produce ABAlife®. This water-only extraction technology preserves the natural properties of the fig while concentrating it’s natural ABA content.

Frequently asked questions (faqs)

ABAlife® is a proprietary fig fruit extract (Ficus carica L.) standardized to abscisic acid (ABA), a naturally occurring bioactive involved in glucose metabolism and metabolic signaling. ABA is naturally present in figs, and ABAlife® provides a consistent and concentrated source suitable for metabolic health formulations.

ABAlife® has been studied for its ability to support glycemic control, insulin sensitivity, and metabolic flexibility. Clinical findings show that ABAlife® can help moderate postprandial blood glucose and insulin responses in healthy individuals.

These properties make it a valuable ingredient for formulations targeting metabolic wellness, healthy glucose management, and postprandial balance.

ABAlife® is produced using Euromed’s Pure-Hydro Process®, a water-only extraction method that preserves the natural ABA content of the fig without the use of organic solvents.

The figs used for ABAlife® are sustainably grown in Spain and processed locally, ensuring traceability, quality, and minimal environmental impact throughout the production chain.

ABAlife® is suitable for a wide range of applications, including dietary supplements, functional foods, beverages, and metabolic health formulations. Its standardized abscisic acid (ABA) content and clinically supported effects on postprandial glucose and insulin responses make it ideal for products targeting glycemic control, metabolic wellness, and healthy glucose management.

Thanks to its water-only extraction, natural origin, and excellent formulation compatibility, ABAlife® performs well in capsules, tablets, powders, bars, and ready-to-mix blends.

Do you want to know more about ABAlife®?

Get in Touch

Download Brochure PDF

HEALTH PROPERTIES

Glycemic Support

Healthy Aging, Prevention

DOWNLOAD EUROMED PRODUCTS

Download PDF

5/5 - (6 votes)

Category	Study Type	Study Findings	Reference	Link
Cardiovascular & Metabolic Health	Animal Study – Endothelial Function	Preserved endothelial function and lower oxidative markers in hypercholesterolemic pigs.	Rev Esp Cardiol. 2015;68(3):216–25.	https://doi.org/10.1016/j.rec.2014.04.021
	Animal Study – Fructose-Fed Rat Model	Lower fat accumulation, microbiota shifts, and urolithin-like metabolites in fructose-fed rats.	Food Funct. 2024;15:7348–7363.	https://doi.org/10.1039/d4fo00688g
	Clinical Study – Cardiometabolic Health	Lower systolic BP, reduced cortisol, and higher quality-of-life scores.	EC Nutr. 2015;2:396–411.	https://www.researchgate.net/publication/341119964
	Clinical Study – Antioxidant Markers	Lower blood pressure and cortisol, higher antioxidant capacity, and urolithin A.	Antioxidants. 2022;11:2124.	https://doi.org/10.3390/antiox11112124
	Clinical Study – Blood Pressure	Lower diastolic blood pressure after 8 weeks.	J Nutr Sci. 2017;6:e39.	https://doi.org/10.1017/jns.2017.36
Healthy Aging	In Vivo – Longevity & AHR Pathway	Extended lifespan in C. elegans; AHR pathway activation in mouse liver.	Int J Mol Sci. 2024;25:9943.	https://doi.org/10.3390/ijms25189943
	Animal Study – Oxidative Stress in Aging Mice	Reduced basal ROS, protected WBC from induced oxidative damage, improved redox balance.	Int J Mol Sci. 2025;26:5957.	https://doi.org/10.3390/ijms26135957
	Clinical Study – IGF-1 & Telomere Biology	Moderate rise in circulating IGF-1; telomere length maintained over 12 weeks.	Nutrients. 2025;17:2974.	https://doi.org/10.3390/nu17182974
Sports Nutrition	Clinical Study – Endurance Performance	Improved time to exhaustion and post-exercise muscle recovery.	Nutrients. 2019;11:721.	https://doi.org/10.3390/nu11040721
Cognition & Behaviour	Animal Study – Frailty Prevention	Improved coordination and neuromuscular function, with lower oxidative damage in aging mice.	Antioxidants. 2023;12:1991.	https://doi.org/10.3390/antiox12111991
	Clinical Study – Acute Cognitive Performance	Faster logical reasoning and improved working-memory performance.	Academic Press; 2021. Chapter 10.	https://doi.org/10.1016/B978-0-12-820593-8.00010-0
	Clinical Study – Satiety & Eating Behaviour	Higher satiety ratings and reduced food intake during a test meal.	Foods. 2022;11:2639.	https://doi.org/10.3390/foods11172639
	Clinical Study – Cognitive Function (55–70 Years)	20% fewer WCST errors; trends toward improved memory and inhibitory control.	Geriatrics. 2025;10:29.	https://doi.org/10.3390/geriatrics10010029
Healthy Inflammatory Response	In Vitro – Inflammasome Activation	Reduced IL-1β release in ATP-stimulated macrophages.	Cell Death Differ. 2016;23:1219–31.	https://doi.org/10.1038/cdd.2015.176
	In Vitro – Corneal Epithelium Model	Lower IL-8 release and higher cell viability in LPS-stimulated corneal epithelial cells.	J Clin Transl Ophthalmol. 2023;1:52–60.	https://doi.org/10.3390/jcto1020007
	Animal Study – TNF-α–Induced Muscle Catabolism	Maintained muscle mass and reduced inflammatory signalling in TNF-α–challenged mice.	Mol Nutr Food Res. 2017;61:1600169.	https://doi.org/10.1002/mnfr.201600169
	Clinical Study – Cytokines & Cardiometabolic Health	Lower IL-6 and IL-1β, with trends in CRP, TNF-α, and systolic BP.	Nutrients. 2025;17:1235.	https://doi.org/10.3390/nu17071235
Skin Health	In Vitro – Photoaging Effects	Reduced UV-induced ROS, enhanced collagen and HA metabolism, and tyrosinase inhibition.	Int J Food Sci Nutr. 2022;74:51–63.	https://doi.org/10.1080/09637486.2022.2152189
Microbial Response	In Vitro – Antimicrobial Activity Assays	Bactericidal and antifungal effects against tested microorganisms.	Int J Mol Sci. 2024;25:6943.	https://doi.org/10.3390/ijms25136943
Gut Health	In Vitro – Proof of Concept	Punicalagin converted into ellagic acid by selected probiotics (urolithin precursor formation).	J Agric Food Chem. 2022;70:16273–16285.	https://doi.org/10.1021/acs.jafc.2c06585

Study Type	Key Findings	Reference
In-vivo Safety Study (Genotoxicity)	No mutation induced. Safe dose: 30mg/day or 2000mg/kg (single dose)	Mutation Research 777 (2015)
Subchronic Toxicity (13 weeks)	No toxicological effect up to 500mg/kg/day	Food Chem Toxicol 84 (2015)
Antimicrobial In-vitro Study	Antibacterial activity (E. coli, S. aureus) and antioxidant packaging effects	Foods 2020, 9, 1339
Human Study (15mg/day, 3 weeks)	Improved body composition, antioxidant status, gene expression (inflammation/oxidative stress)	Oxid Med Cell Longev. 2017
Antioxidant, CV Support (acute dose)	Strong antioxidant effect, reduced lipid peroxidation, SOD up-regulation	Biomedicine & Prevention 2017
Breast Cancer Patients (adjunct to chemo)	Reduced TIMP-1 levels, potential for improved prognosis	Antioxidants 2019, 8, 393
Exploratory Stroke Study (humans)	Reduced HbA1c, diastolic BP, improved neurological/functional outcomes	Int. J. Mol. Sci. 2024

FIG FRUIT EXTRACT – ABAlife®

Frequently asked questions (faqs)

What is ABAlife®?+

What health benefits are associated with ABAlife®?+

How is ABAlife® produced?+

In which types of products can ABAlife® be used?+

Do you want to know more about ABAlife®?

HEALTH PROPERTIES

DOWNLOAD EUROMED PRODUCTS